Skip to main content
PLOS One logoLink to PLOS One
. 2025 Aug 1;20(8):e0329458. doi: 10.1371/journal.pone.0329458

Adherence to iron-folic acid supplementation and its associated factors among pregnant women in Kenya: A multilevel data analysis of the 2022 Kenyan Demographic and Health Survey

Gebrie Getu Alemu 1,*, Dagnew Getnet Adugna 2, Amare Mesfin 3, Muluken Chanie Agimas 1, Lemlem Daniel Baffa 3, Habtamu Wagnew Abuhay 1, Mekuriaw Nibret Aweke 3, Tewodros Getaneh Alemu 4, Nebebe Demis Baykemagn 5
Editor: Kanchan Thapa6
PMCID: PMC12316296  PMID: 40748912

Abstract

Background

Iron and folic acid deficiency is a global public health issue, particularly in low- and middle-income countries. Adherence to iron-folic acid supplementation (IFAS) remains low in Kenya. Despite several studies on IFAS adherence in Kenya, they do not assess the national scope and clustering effects using advanced analytical models. Therefore, we aimed to assess IFAS adherence and its associated factors among pregnant women in Kenya using data from the 2022 Kenyan Demographic and Health Survey.

Methods

A secondary data analysis was conducted using data from the 2022 Kenya Demographic and Health Survey, which was obtained from the official Demographic and Health Survey program database. Weighted samples of 8,460 participants were used in the analysis. The study employed a multivariable multilevel mixed-effects logistic regression model. Variables from the bi-variable model that had p < 0.25 were considered in the multivariable analysis. Variables with a p-value < 0.05 were considered statistically significant in the multivariable model, and the adjusted Odds Ratio (aOR) with its 95% CI was reported.

Results

The prevalence of IFAS among pregnant women in Kenya was 61.72% (95% CI: 60.68, 62.75). Women aged 20–39 years were 1.3 to 1.7 times more likely to adhere to IFAS during pregnancy, with the likelihood increasing steadily by age group. Moreover, primigravida [aOR = 1.22 (95% CI: 1.06, 1.41)], with a family size of ≥ 10 [aOR = 0.72 (95% CI 0.59, 0.90)], antenatal care visits ≥ 4 [aOR = 3.96 (95% CI: 1.91, 8.23)], first start of antenatal care at the third trimester of pregnancy [aOR = 0.30 (95% CI: 0.15, 0.62)], and with a higher level of education [aOR = 1.6 (95% CI: 1.35, 1.90)] were statistically significant factors associated with adherence to IFAS.

Conclusion and recommendation

Nearly two in five pregnant women didn’t receive IFAS for the recommended periods. Factors such as maternal age, parity, antenatal visits, and education enhanced IFAS adherence, whereas large family size and starting antenatal care in the third trimester of pregnancy reduced adherence. Therefore, the community, government, and non-governmental organizations should enhance adherence by implementing customized interventions on the factors identified as positive and negative associations.

Introduction

Adherence in a medical context refers to how well a patient follows a prescribed treatment plan, which is essential for optimal health outcomes [1,2]. Iron, a key component of hemoglobin, is essential for blood formation and oxygen transport. Iron deficiency, one of the most preventable dietary deficiencies, commonly affects women during pregnancy [3]. Iron-folic acid supplementation coverage is a core process indicator of the Global Nutrition Monitoring Framework (GNMF) among pregnant women [4].

Studies have shown that the risk of megaloblastic anemia in pregnant women is dramatically lowered by folic acid supplementation, usually taken with iron. For example, pregnant women given folic acid and iron rather than iron only had a reduction in megaloblastic anemia from 13% to 5%. Besides, periconception IFAS is effective in reducing the risk of neural tube defects (NTDs) such as spinal bifida and anencephaly. Even if iron is often combined with folic acid in supplements primarily to address anemia, the NTD prevention benefits are attributable to folic acid [5,6].

Poor adherence to IFAS is a critical public health challenge in sub-Saharan Africa (SSA). While adherence to IFAS during pregnancy in high-income countries ranges from 77% in Denmark [7] to 85% in Sweden [8], adherence to IFAS among pregnant women in Kenya has been reported to be as low as 10.6% [9]. A population-based survey performed in Brazil reported that the prevalence of IFAS among pregnant women was 59% [10]. Another study done in India showed that the overall compliance of IFAS was reported to be 64.7% [11]. A large population-based study conducted in 22 SSA countries showed that the overall prevalence of adherence to IFAS among pregnant women was only 28.7% [12]. A systematic review and meta-analysis in SSA revealed that the estimated pooled prevalence of IFAS among pregnant women was 39.2% [13]. Different studies conducted in Ethiopia showed that the prevalence of adherence to IFAS among pregnant women ranged from 17.1% to 84% [1418]. A study conducted in Tanzania showed the prevalence of IFAS was 22% [19]. Similarly, the prevalence of adherence to IFAS among pregnant women in Kenya ranged from 10.6% [9] to 60.4% [2].

Iron deficiency is a global public health issue, especially in low- and middle-income countries. Iron’s limited bioavailability and high prenatal iron needs, particularly in developing nations, raise concerns about the need for additional iron sources such as supplements. The World Health Organization (WHO) recommends routine iron supplementation for all pregnant women in response to the increased demand [20]. To meet the nutritional needs of the growing fetus and their own, pregnant women need more iron and folic acid. Iron and folic acid deficiencies during pregnancy may have detrimental effects on the mother’s health and the development of the fetus. Pregnant women are required to take 400 µg (0.4 mg) of folic acid and 30–60 mg of elemental iron orally every day to prevent maternal anemia, puerperal sepsis, a low birth weight, and premature birth [20]. Taking iron supplements during pregnancy can reduce pregnancy-related complications like low birth weight, preterm birth, and postpartum hemorrhage [17].

Anaemia in pregnancy is defined as a hemoglobin (Hgb) content of less than 11 g/dl [21]. It affects almost two billion people worldwide [22]. Anaemia has been observed in about 37% of pregnant women worldwide, with Africa bearing the brunt of this condition despite the provision of iron-folic acid during their antenatal care [23]. According to a recent systematic review and meta-analysis, 35.6% of pregnant women in SSA suffered from pregnancy-related anaemia [13].

In Kenya, the most current micronutrient survey in the country indicated the prevalence of anaemia due to iron deficiency is thought to affect 55.1% of pregnant women [24]. Pregnancy-related anemia is a public health issue that can result in several potentially fatal consequences as well as unfavorable pregnancy outcomes [25]. One of the major global public health issues, accounting for 1.45% of all disability-adjusted life years, is iron and folic acid deficiency anemia. An excessively high percentage of maternal and perinatal illness and mortality is acknowledged to be caused by it [14].

Iron deficiency anemia (IDA) is the most common type of anemia that occurs during pregnancy and is associated with a wide range of nutritional deficiencies that can have detrimental effects on both the mother and the fetus. Most women’s stocks of iron are insufficient to fulfill the sharply increased needs during the second and third trimesters of pregnancy. Due to increased dietary requirements, such as those for iron, folate, and vitamin B12, as well as hemodilution during pregnancy, pregnant women are at risk of developing anemia [26]. Maternal anemia’s pathogenesis has been connected to iron deficiency, and it significantly contributes to pregnancy-related morbidity and mortality [2]. It is accompanied by an increased risk of maternal mortality, obstetric problems, preterm delivery, and low birth weight [27].

Numerous studies have stated the relationship between different factors and adherence to IFAS. Age of the mother [12,17], place of residence [1], marital status of the mother [12], level of education [1,2,12,27,28], household wealth index [12,27], number ANC visits [1,12,16,17,27,28], timing of ANC visit [12,14,16], birth intervals (parity) [2,16], family size [17], lack of information about the need for IFAS [29], media exposure [27], and distance to health facility [12,27] were significant predictors of adherence to IFAS.

Supplementing with iron-folic acid is a useful strategy to lower the incidence of anemia during pregnancy [30]. It is critical to follow iron supplements throughout pregnancy to minimize anemia and the morbidities that come with it. Pregnant women who receive and use iron supplements appropriately reduce the risk to their health and the health of their unborn children [14]. Iron supplements help prevent and treat anemia in pregnant and postpartum women, improving maternal and perinatal health [31]. Iron-folic acid supplements should be given to all pregnant mothers regularly [17]. Pregnancy increases dietary needs, making iron supplements essential for health. Pregnant women in Kenya can receive free supplements at public health institutions during prenatal appointments, but uptake remains low [2].

Providing and properly using IFAS during pregnancy can help prevent health risks for both the mother and the baby. Iron-folic acid is essential for pregnant women because it supports the mother’s increased blood volume, helps prevent anemia, and contributes to the baby’s development. Adequate supplements can improve maternal health, reduce the risk of complications during pregnancy, and lead to better health outcomes for the baby, both at birth and in the early stages of life. There is no national representative information regarding IFAS among pregnant women in Kenya. Performing a countrywide analysis with recent nationally representative Demographic and Health Survey (DHS) data in Kenya is essential for identifying common determinants in the country. Reducing maternal mortality is a key indicator for achieving the third Sustainable Development Goal (SDG) on good health and wellbeing, aiming to lower maternal deaths to less than 70 per 100,000 live births. Therefore, we aimed to determine the prevalence of iron-folic acid supplementation and its associated factors among pregnant women in Kenya.

Methods

Study setting

Kenya is an East African country that shares borders with five other countries: Uganda to the West, South Sudan to the Northwest, Ethiopia to the North, Somalia to the East, and Tanzania to the South. Its Southeast flank abuts the Indian Ocean. The total area of Kenya encompasses approximately 580,650 km2 with a total population of 57,212,424. With an area of 71,597.8 sq. km, Turkana is the largest county, while Nairobi, which is the national capital city, is the most populous one with a population of 4,397,075 [32,33]. Kenya, a low and middle-income African country, is divided into 47 administrative regions, each categorized into rural and urban areas, with 92 strata, since Nairobi City and Mombasa counties are purely urban [34]. Kenya’s health system, managed by national and county governments, operates through a six-tier structure, involving community units and tertiary Referral Hospitals. Despite progress, the quality of health services remains insufficient due to poor infrastructure and availability [35].

Study design

Secondary data analysis was done on Kenya Demographic and Health Survey (KDHS) 2022, which was collected by using a cross-sectional study design.

Study period

Data used were collected from Kenyan women of reproductive age who are in the ages of 15–49 years, with data collection taking place from February 17 to July 19, 2022, in all counties of the country [36].

Data source and sampling procedure

The data were accessed from the official database of the DHS program (www.measuredhs.com) after permission was secured through an online request by explaining the purpose of this study. The DHS is a population-based survey that is nationally representative and is gathered using standard questions and equivalent national manuals. The DHS collects a variety of objective and self-reported data with a particular focus on indicators of fertility, reproductive health, mother and child health, mortality, nutrition, and self-reported health characteristics among adults. High response rates, nationwide reach, excellent interviewer training, uniform data collection practices across nations, and constant content over time are some of the DHS’s main advantages. The KDHS 2022 was used to draw this study data. In Kenya, the 2022 KDHS is the seventh survey of its kind. The 2022 KDHS samples were selected using a two-stage stratified cluster sampling technique to select study participants based on the 2019 Kenya Population and Housing Census (KPHC) as a sampling frame. In the first stage, 1,692 clusters were selected from the Kenya Household Master Sample Frame (K-HMSF) using the Equal Probability Systematic Sampling Method (EPSSM). In every sampling stratum, the clusters were selected independently. All the clusters that were chosen had their homes listed, and the resulting list of households was used from each cluster. All the households from these clusters were chosen for the sample because, following the household listing method, it was discovered that certain clusters contained less than 25 households. The 2022 KDHS sample was designed to be a reliable estimate at the national level, for rural and urban areas individually, and, for some variables, at the county level for each of the forty-seven counties, which comprised 42,022 households [34]. Interviews were conducted face-to-face using tablet computers with computer assisted personal interviewing technology. Interviews were available for all women aged 15–49 who regularly resided in the chosen houses or who spent the night before the survey there. The 2022 KDHS interviewed a nationally representative sample of 32,156 women aged 15–49; of these, 11,863 women had recently given birth within the five years preceding the survey [34]. Among 11,863 women who had recently given birth within the five years preceding the survey, 9,312 women had at least one ANC follow-up. Among those women who had at least one ANC follow-up (9,312), 344 were excluded because they did not take IFAS and for incompleteness. Finally, 8,969 (8,460 weighted) samples were included in the final analysis, and it was inquired of them how many days they had taken iron tablets or syrups during their previous pregnancy (Fig 1).

Fig 1. Flow diagram of the 2022 KDHS sampling design and data extraction process.

Fig 1

Source and study population

Source population.

All Kenyan women aged 15–49 years, who had a live birth in the five-year preceding 2022 KDHS. Out of 32,156 women who responded the questionnaire, 11,863 had given birth in the five years before the 2022 KDHS [34].

Study population.

The study population consisted of Kenyan women aged 15–49 who had a live birth between 2017 and 2022, five years preceding the 2022 KDHS. Women who attended at least one ANC visit (9,312) were included and only information pertaining to the most recent pregnancy were used.

Ethical approval and consent to participate

The Institutional Review Board (IRB) of the Inner-City Fund (ICF) granted ethical approval for the 2022 KDHS. The Kenya National Bureau of Statistics conducted the survey in collaboration with other development partners. Written informed consent was obtained from all participants or the legally appointed representative of minor participants. Respondents participated voluntarily without coercion [37], and all data are Health Insurance Portability and Accountability Act (HIPAA) protected and de-identified. These ethical issues were addressed by those who conducted the primary surveys, not the current authors of the manuscript. Since this study employed already-existing public domain survey data sets with all identifiers’ information removed that are freely accessible online at www.measuredhs.com, ethical approval was not necessary because it was taken with ICF. However, we had an authorization letter from Measure DHS to access and utilize the data by submitting an online request.

Measurement of variables

Dependent variable.

The outcome variable in this study was adherence to iron-folic supplementation during recent pregnancy. Adherence to IFAS was defined as taking iron tablets or syrups for ≥ 90 days during antenatal care. Adherence to IFAS in the DHS data was measured by the number of days iron tablets or syrups were taken during antenatal care, with ≥ 90 days selected based on WHO guidelines [38].

Independent variables.

Individual and community-level variables were considered independent variables based on the DHS data and literature review (S1 Table).

Individual level variables: maternal age, marital status, education, occupation, wealth, history of pregnancy termination, ANC attendance and timing, household head’s sex, birth interval, family size and perceived distance to the health facility.

Community-level independent variables: Previous studies used mean or median values to aggregate individual-level characteristics into community variables [39,40].

Place of residence (urban, rural) was originally recorded, so aggregation was not needed.

Media exposure was measured by the percentage of women exposed to at least one form of media, such as television, radio, or newspapers. Participants exposed to at least one of the three media were labeled “exposed” and coded as “1”; otherwise, “not exposed” was coded as “0”.

Community education: This aggregate variable represents the percentage of women in the community with low or high education. Values below the median are classified as low, while those at or above the median are classified as high.

Community wealth index: Women were categorized by the community wealth index based on their households as living in poor or rich households. The percentage of women in each category was calculated, and communities were classified as “low” (< 45.58%) or “high” (≥ 45.58%) using the median percentage as the cutoff.

Community-level women’s education, media exposure, and wealth index were created by aggregating individual-level data, as these variables were not directly available in the DHS. Since they were not normally distributed, the median was used to categorize communities as low or high based on the proportion of women’s education, media exposure, and wealth index.

Statistical analysis

STATA 17 was used for data extraction, recoding, and analysis. Weighting was applied to enhance sample representativeness, ensure population resemblance, and obtain reliable estimates. The hierarchical structure of KDHS data violates the classical logistic regression model’s assumptions of independent observations and equal variance. Pregnant women are nested within a cluster, and we expect that pregnant women within the same cluster may be more similar each other than pregnant women found in different clusters. This highlights the need to use a multilevel mixed-effect logistic regression model to account for variability between clusters. Therefore, a multilevel mixed-effect logistic regression model was fitted to estimate the association between the individual and community-level variables and adherence to iron-folic acid supplementation.

Cluster variation was quantified using the Intra Class Correlation Coefficient (ICC), Median Odds Ratio (MOR), and Proportional Change in Variance (PCV). The ICC measured the similarity of individuals within a cluster, distinguishing it from cluster heterogeneity [41]. In this study, ICC was used for understanding how much of the adherence variability is explained by cluster differences rather than individual differences. The intra-class correlation was calculated as the proportion of the between-community variation in the total variation alive.

ICC=σ² σ² +τ0²\] (1)

where, σ²\) is the cluster level variance and τ0²\) is the individual level variance.

The ICC/Rho from the empty model tells how much of the total variance in the adherence to iron supplementation is accounted for by the clustering or grouping structure of the data. A high ICC (closer to 1) indicates substantial clustering; meaning individuals within the same group are more similar to each other than to individuals from different groups. This suggests the need to account for the clustered nature of the data using a multilevel model. A low ICC (closer to 0) indicates little clustering, meaning there is more variation within groups than between groups. This suggests the clustered structure may not be important, and a single-level model may be sufficient.

When we select two random clusters, the MOR is the median value of the odds ratios between the areas with the highest and lowest risk. It can be understood as when someone moves from a low-risk cluster to a higher-risk cluster, they are exposed to a greater degree of risk. In this study, the MOR shows the individual increased risk of adherence to IFAS when someone moves from cluster with low probability of adherence to IFAS to area with high risk of adherence to IFAS. The MOR is always greater than or equal to 1. The likelihood of adherence to IFAS would not vary among clusters if MOR was equal to 1 [42].

               MOR=exp(2*σ2*0.6745  )=exp(0.95σ²  )\] (2)

where; 0.6745 is the 75th centile of the cumulative distribution function of the normal distribution with mean 0 and variance of 1, and σ2\) is the cluster level variance.

Proportional (percentage) change in variance is a measure of total variation attributed to individual-level factors and community-level factors in the multilevel model as compared to the null model [42].

PCV= σ²null σ²varσ²null        \] (3)

where; σ²null\) is variance of the initial model without any explanatory variable (empty model) and σ2var is the variance of the model with determinant factors. I.e. model two with individual level determinant factors, model three with community level factors and model four (full model) with both individual and community level determinant factors alive.

For the multilevel mixed-effect logistic regression analysis, four models were constructed. The first model was the empty model without determinant factors to assess cluster variation in IFAS adherence. The second model includes individual-level explanatory variables and adherence to IFAS; the third model includes community-level explanatory variables and adherence to IFAS, whereas the fourth model includes both individual- and community-level explanatory variables at the same time and adherence to IFAS.

Akaike’s Information Criterion (AIC), Bayesian information criterion (BIC) and Log-Likelihood (LL) were used to compare and select the best-fitted model and a model with the lowest AIC, BIC and the largest LL was considered the best-fitted model (Model-IV). Multicollinearity among the independent variables was checked by Variance Inflation Factor (VIF) and tolerance. As a result, there was no multicollinearity because VIF of each independent variable were < 7. Variables from the bi-variable model that had a p-value less than 0.25 were considered in the multivariable analysis. Finally, aOR with a 95% Confidence Interval (CI) was reported, and variables with p-value < 0.05 in the multivariable multilevel mixed-effect logistic regression were identified as significant predictors of adherence to iron-folic acid supplementation.

Results

Characteristics of the study participants

A weighted sample of 8,460 pregnant women aged 15–49 was included in the study. Nearly one-third (29.34%) were aged 25–29, more than two-thirds (70.34%) were from male-headed households, and about 79.14% were married/living with a partner. Regarding the occupational status of the pregnant women, about 43.32% were unemployed. One-third (29.73%) of the study participants perceived distance to the health facility as a big problem. Only about one-third (32.03%) of the survey respondents had received four or more ANC visits, and most (59.95%) began ANC in the second trimester. Additionally, the majority (72.55%) of women were multigravida. Furthermore, more than two-thirds (70.29%) of the study participants had a prenatal nurse/midwife at the most recent birth. Regarding the community-level characteristics, the majorities (62.17%) of the study participants were rural dwellers, and about 44.94% were from literate communities. Finally, about 61.68% of the study participants were from a high level of community wealth, whereas about 60.60% had community media exposure (Table 1).

Table 1. Individual and community level weighted socio-demographic characteristics of the pregnant women in Kenya, KDHS 2022.

Characteristics (variables) Category Weighted frequency
(N = 8460)
Weighted percentage (%)
Maternal age (Years) 15-19 589 6.96
20-24 2,270 26.83
25-29 2,482 29.34
30-34 1,641 19.40
35-39 1,033 12.20
40-49 445 5.27
Sex of the
household head
Male 5,990 70.80
Female 2,470 29.20
Marital status Never married 1,025 12.12
Married/living with partner 6,696 79.14
widowed/divorced/separated 739 8.74
Maternal occupation Not working 3,665 43.32
Working 4,795 56.68
Perception of the
distance to health
facility
A big problem 5,945 70.27
Not a big problem 2,515 29.73
Currently pregnant No 8,020 94.80
Yes 440 5.20
Parity Primipara 2322 27.45
Multipara 6138 72.55
Family size 1-4 3,502 41.40
5-9 4,471 52.85
10+ 487 5.75
ANC visit 1-3 5,750 67.97
≥4 2,710 32.03
Timing of first
ANC visit
First trimester 2,685 31.74
Second trimester 5,072 59.95
Third trimester 703 8.30
Prenatal nurse/midwife No 2,514 29.71
Yes 5,946 70.29
Residence Urban 3,200 37.83
Rural 5,260 62.17
Community literacy Low 4658 55.06
High 3802 44.94
Community wealth Low 5,218 61.68
High 3,242 38.32
Community media exposure Low 3,333 39.40
High 5,127 60.60

The prevalence of iron-folic acid supplementation among pregnant women in Kenya was 61.72% (95% CI: 60.68, 62.75) (Fig 2).

Fig 2. Adherence level of iron-folic acid supplementation among pregnant women in Kenya, KDHS 2022.

Fig 2

Factors associated with adherence to iron-folic acid supplementation among pregnant women in Kenya

A multilevel mixed-effects binary logistic regression model was used to identify potential factors affecting IFAS adherence. The final model (model-IV) was deemed suitable for identifying individual and community-level variables associated with IFAS adherence in Kenya, following an evaluation of model fitness using various post-estimation methods, including AIC, BIC, and LL. The variability in adherence to IFAS among pregnant women attributed to cluster-level variability was 15.77% (95% CI: 13.32, 18.58) based on the estimated ICC, while 84.33% was attributed to individual-level factors (Table 2).

Table 2. Random effect analysis and model comparison for adherence to IFAS among pregnant women in Kenya, KDHS 2022.

Random effect Model-I (Empty) Model-II Model-III Model-IV
ICC % 15.77 (13.32, 18.58) 14.32 (11.84, 17.22) 14.46 (12.09, 17.22) 13.76 (11.31, 16.63)
MOR 2.1 2.04 2.03 1.99
PCV Ref. 0.091 0.097 0.144
Model Fitness
Log Likelihood −5923.3385 −5524.0175 −5883.029 −5506.3737
AIC 11850.68 11092.03 11778.06 11064.75
BIC 11864.88 11249.25 11820.67 11248.36

AIC: Akaike Information Criterion; BIC: Bayesian information criterion; ICC: Intra Class Correlation Coefficient; Ref: Reference; MOR: Median Odds Ratio; PCV: Proportional Change in Variance.

Fifteen independent variables with p < 0.25 in the bivariable analysis were included in the multivariable multilevel mixed-effects logistic regression. At a 95% confidence level, the significant factors associated with IFAS identified from the best-fitted model (model-IV) were maternal age, parity, family size, number of ANC visits, timing of first ANC visit, and educational level of the mother.

Being in the age group from 20–24 years was 1.32 times more likely to adhere to iron-folic acid as compared with the age group from 15–19 years [aOR = 1.32 (95% CI: 1.07, 1.63)]. Moreover, women aged 25–29 years were 1.47 times [aOR = 1.47 (95% CI: 1.17, 1.85)] more likely to have adherence to iron-folic acid as compared to women aged 15–19 years. Furthermore, women aged 30–34 years were 1.56 times [aOR = 1.56 (95% CI: 1.21, 2.01)] more likely to have adherence to iron-folic acid as compared to women aged 15–19 years. Being in the age group from 35–39 years was 1.67 times more likely to adhere to IFAS as compared with those aged 15–19 years [aOR = 1.67 (95% CI: 1.27, 2.19)].

Parity is one of the determinant factors associated with IFAS. The odds of adherence to IFAS were 1.22 times [aOR = 1.22 (95% CI: 1.06, 1.41)] higher among primipara women compared with multipara. Those with larger families were less likely to take iron-folic acid during pregnancy. The odds of adherence to IFAS among pregnant mothers with a family size of ≥ 10 were reduced by 28% [aOR = 0.72 (95% CI 0.59, 0.90)] compared to those with a family size of 1–4.

In terms of ANC, the odds of adherence to IFAS were nearly four times [aOR = 3.96 (95% CI: 1.91, 8.23)] higher for mothers who attended the minimum four ANC visits compared to those who didn’t attend the minimum four ANC follow-ups. The odds of adherence to IFAS were decreased by 70% [aOR = 0.30 (95% CI: 0.15, 0.62)] among mothers who first started iron-folic acid at the third trimester of pregnancy compared to those who began iron-folic acid at the first trimester of pregnancy. Finally, pregnant women with a higher level of education were 1.6 times more likely to follow IFAS compared to those with low levels of education [aOR = 1.63 (95% CI: 1.35, 1.90)] (Table 3).

Table 3. Multi-level logistic regression analysis of individual and community level factors associated with IFAS among pregnant women in Kenya, KDHS 2022.

Characteristics Category aOR (95% CI)
Model I
(empty)
Model II Model III Model IV P-value
Maternal age
(Years)
15-19 1 1
20-24 1.34 (1.09, 1.66) ** 1.32 (1.07, 1.63) * 0.010
25-29 1.47 (1.17, 1.85) ** 1.47 (1.17, 1.85) ** 0.002
30-34 1.47 (1.15, 1.88) ** 1.56 (1.21, 2.01) ** 0.002
35-39 1.51 (1.16, 1.96) ** 1.67 (1.27,2.19) *** < 0.001
40-49 1.39 (0.94, 1.75) 1.48 (0.96, 2.07) 0.163
Sex of the
household head
Male 1 1
Female 1.05 (0.93, 1.19) 1.08 (0.96, 1.21) 0.211
Marital status Never married 1 1
Married 0.99 (0.82, 1.20) 1.05 (0.87, 1.27) 0.664
Separated 0.85 (0.67, 1.07) 0.88 (0.69, 1.12) 0.291
Maternal occupation Not working 1.00 (0.90, 1.11) 1.06 (0.96, 1.19) 0.248
Working 1 1
Perception of the
distance to HF
Not a big
problem
1 1
A big problem 0.95 (0.86, 1.06) 0.96 (0.87, 1.07) 0.425
Currently pregnant No 1 1
Yes 0.97 (0.79, 1.19) 1.01 (0.82, 1.23) 0.938
Parity Primipara 1.27 (1.09, 1.46) ** 1.22 (1.06, 1.41) ** 0.007
Multipara 1 1
Family size 1-4 1 1
5-9 0.88 (0.78, 0.99) 0.89 (0.79, 1.00) 0.056
10+ 0.69 (0.56, 0.85) *** 0.72 (0.59, 0.90) ** 0.001
ANC visit 1-3 1 1
≥4 3.48 (1.68, 7.22) *** 3.96 (1.91,8.23) *** < 0.001
Timing of first ANC visit First trimester 1 1
Second trimester 1.79 (0.86, 3.75) 2.05 (0.98, 4.29) 0.061
Third trimester 0.27 (0.13, 0.54) *** 0.30 (0.15,0.62) *** < 0.001
Prenatal nurse/midwife No 1 1
Yes 1.05 (0.94, 1.18) 1.08 (0.96, 1.21) 0.211
Residence Urban 1 1
Rural 0.94 (0.82,1.08) 0.98 (0.85, 1.13) 0.806
Community literacy Low 1 1
High 1.63 (1.39,1.91) *** 1.60 (1.35,1.90) *** < 0.001
Community poverty Low 1 1
High 0.81 (0.72,0.92) 0.93 (0.81, 1.06) 0.174
Community media exposure Low 1
High 1.03 (0.89,1.17) 0.97 (0.84, 1.10) 0.661

aOR; adjusted Odds Ratio, CI; Confidence Interval, 1; Reference category, ANC; Antenatal care, HF; Health Facility, *P < 0.05, **P < 0.01, ***P < 0.001. Note: The included P-values were for Model IV.

Discussion

The prevalence of IFAS among pregnant women in Kenya was 61.72% (95% CI: 60.68, 62.75). Maternal age, parity, antenatal visits, education, family size, and starting time of ANC were factors significantly associated with adherence to IFAS.

This study found that only 61.72% of mothers in Kenya took IFAS according to WHO recommendations. This study is consistent with studies conducted in Kenya (60.6%) [2], and Ethiopia (60.9%) [43]. The reason could be that since the study results are consistent with findings in Ethiopia and other Kenyan studies, it suggests a broader trend across similar regions. Moreover, these countries have implemented national policies promoting IFAS during pregnancy as part of ANC programs. Furthermore, Kenya and Ethiopia experience overlapping public health concerns, such as malnutrition and maternal health challenges, leading to similarities in medical and epidemiological studies.

The prevalence of IFAS in this study exceeded rates reported in Kenya (10.4%) [9], (32.7%) [44], Ethiopia (18.97%, – 56.5%) [1,12,1416,27,45], Tanzania (20.3%) [46], Ghana (58.8%) [47], SSA (28.7%) [12] and Brazil (59%) [10]. The discrepancy could stem from study design, because most individual studies focus on institution-level ANC follow-ups. In contrast, this study employed a large-scale survey, and others relied on meta-analysis [48]. Moreover, the observed difference could be attributed to study periods, sample size, study setting, and sociodemographic characteristics [49,50]. Furthermore, enhanced health-seeking behavior and increased ANC visits could have contributed to higher adherence [36,48].

This study’s finding was lower than those reported in Ethiopia (84%) [30], Niger (68.6%) [51], India (71%) [52], Denmark (77%) [7] and Sweden (85%) [8]. The difference could be attributed to the intermittent nature of DHS data collection (once every 5 years), leading to potential recall bias and underestimation of IFAS adherence, lack of knowledge of IFAS, and absence of supply chain information [48]. Moreover, the lower IFAS adherence in Kenya compared to others could be due to a combination of supply chain issues, inadequate counseling, lack of knowledge and information about maternal anemia and the benefits of IFAS among both pregnant women and health care providers, broader socio-economic barriers, and inaccessibility to ANC services, especially in rural and marginalized areas [2,53].

In this study, older women showed higher IFAS compliance than younger women, with those aged 20–24, 25–29, 30–34 and 35–39 years were more likely adhered compared to those aged 15–19. Our findings aligned with studies conducted in Ethiopia [17,54], Tanzania [19] Sudan [55], SSA [12], India [56] and Brazil [57]. The correlation between IFAS adherence and age may be explained by older women’s knowledge of the advantages of iron supplementation benefits or their personal experiences with iron deficiency. Older women may be more prone to anemia due to recurrent pregnancies and relay on iron supplements prevention. They may also be more health-conscious, receive family support, and have greater experience in managing iron deficiency anemia [10]. Pregnant adolescents often feel shy, and in this community, their pregnancies may be perceived as unusual. Unplanned pregnancies further worsen the situation, leading to stress and reducing their likelihood of seeking ANC services. Discomfort with medical professionals also discourages ANC visits, and decreasing motivation [11]. This finding highlights the Ministry of Health (MoH) to equip healthcare workers with the necessary skills and knowledge to support these mothers and facilitate their cares.

Pregnant women from families with ≥ 10 members were 28% less likely to adhere to IFAS than those from smaller families (1–4 members), aligning with findings from a study in Ethiopia [17]. The reason may be because mothers with larger families attend ANC less frequently due to household responsibilities and caregiving duties [19]. Large family size often means limited financial and material resources could be shared among more individuals, which can reduce the priority given to maternal health needs, such as IFAS adherence. In such households, pregnant women may face increased domestic and caregiving responsibilities, leading to time constraints and forgetfulness, which are recognized barriers to supplement adherence. In large families, individual health support may be weaker, as attention and encouragement are key to IFAS compliance, and can be spread when there are many dependents [58,59].

Parity is a significant factor in IFAS adherence. Primiparous mothers are 1.22 times more likely to comply than multipara respondents, aligning with studies in Kenya [2,44] and India [60]. The reason could be that primipara mothers are more likely to adhere to IFAS due to increased motivation, better engagement with ANC, higher perceived risk, and fewer competing responsibilities [61]. However, this findings contrasts with studies in Ethiopia, where multipara mothers were more likely to adhere to IFAS than primipara mothers [61]. The reason could be that women with positive birth histories or severe iron-folic acid side effects may not fully recognize the importance of continued supplementation in later pregnancies [29]. This implies that regardless of prior experiences, educating multigravida mothers on the importance of IFAS adherence in subsequent pregnancies is essential.

Mothers who attended the minimum recommended ANC visits had higher iron-folic acid compliance. Mothers who attended at least four ANC visits had nearly four times higher odds of IFAS adherence than those who did not. This finding is consistent with studies conducted in Kenya [2], Ethiopia [62,63], and SSA [12]. The reason could be that more ANC visits increase contact between mothers and healthcare professionals, providing opportunities for supplement counseling and supply replenishment. These visits also allow mothers to discuss challenges and receive guidance. Encouraging pregnant women to complete the WHO-recommended eight visits can enhance IFAS compliance [62,63].

The time of the first ANC visit significantly affects IFAS adherence. Mothers who began ANC in the third trimester were 70% less likely to adhere than those who started in the first trimester, consistent with studies in Ethiopia [16,64,65]. The reason could be that early ANC visits improve IFAS adherence because supplementation should begin as soon as possible; however, many women delay IFAS initiation by realizing their pregnancy only after the first trimester. Early IFAS is recommended, and adherence is strongly influenced by the timing of the first ANC visit [66]. This highlights the necessity of customized interventions to consider the early commencement and difficulties faced by pregnant women to guarantee optimal adherence to IFAS throughout pregnancy.

Higher education levels were positively associated with IFAS adherence, with educated pregnant women nearly twice as likely to use iron-folic acid supplements compared to those with lower education. This finding is similar to studies conducted in Kenya [2], Ethiopia [1,12,27], Senegal [67], SSA [12], India [68] and Pakistan [69]. The reason could be that education plays a vital role in informing expectant mothers about iron deficiency and its management. This suggests that pregnant women with higher education levels are more likely to utilize maternal health services, including iron supplements. Education is essential in increasing pregnant women’s knowledge of iron deficiency and guiding them on how to manage it. Pregnant women with higher education levels are better equipped to benefit from maternal health treatments like iron-folate supplements. They are more informed about pregnancy risks and have greater access to knowledge on the benefits of iron supplementation through various resources [12,43,67].

Strengths and limitations of the study

One of the strengths of this study is the use of nationally representative weighted data, which allows for generalizability at the national level. A multilevel analysis accounts for hierarchical data structure (individual and community), providing more accurate results. The findings will help to address a major public health problem in LMICs, where iron deficiency anemia contributes to maternal and child morbidity and mortality. The findings will also help to improve counseling and interventions for neural tube defects, megaloblastic anemia, and iron deficiency anemia. It will directly support SDG 3 (Good Health and Well-Being) by improving maternal and child health outcomes. We found suboptimal IFAS adherence among pregnant women in Kenya when compared with WHO guidelines, indicating a need for immediate and targeted interventions. Legislators and decision-makers can use these insights to optimize ANC services and support adherence within the existing health systems. This study also offers baseline data to inform healthcare providers, managers, and NGOs to implement an evidence-based intervention in pregnant women concerning IFAS adherence. Strengthening ANC services, health education, and adherence support is important for reducing anemia, obstetric complications, preterm birth, low birth weight, maternal and perinatal mortality. In summary, this study goes beyond standard DHS reports by employing advanced analytical techniques to uncover context-specific determinants of IFAS adherence in Kenya, offering actionable insights for policymakers and program implementers.

Potential recall bias from self-reported data collected over the preceding five years is one of the study’s limitations. However, this bias was reduced by using data from the most recent pregnancy, and it was further minimized by using standardized DHS questionnaires. Additionally, there are inherent limitations due to the data’s cross-sectional nature. Due to the use of secondary sources, certain predictors were not available in the 2022 KDHS data, including cultural factors, household activities, and maternal decision-making. Further studies should use qualitative inquiry to explore how sociocultural and economic factors affect Kenyan pregnant women’s adherence to IFAS. This method will provide more thorough and accurate recommendations for enhancing adherence by considering the specific barriers and facilitators.

Conclusion and recommendation

Iron-folic acid supplementation adherence among pregnant women in Kenya was moderate. Nearly two out of every five pregnant women didn’t receive IFAS for the recommended periods. Maternal age, parity, family size, education, ANC visits and timing were key factors influencing IFAS adherence. Training should be provided to frontline healthcare professionals at all levels to enhance IFAS compliance in the workplace. The MoH should improve maternal health services by emphasizing younger women (15–19 years) and women with 10 or more families, as they are less likely to adhere to IFAS. Researchers should also do further qualitative studies that concentrate on other areas of IFAS adherence barriers.

Supporting information

S1 Table. Lists of individual and community level factors affecting adherence to iron-folic acid supplementation among pregnant women in Kenya, KDHS 2022.

(DOCX)

pone.0329458.s001.docx (13KB, docx)

Acknowledgments

We would like to acknowledge the MEASURE DHS project for their support and free access to the 2022 KDHS original dataset.

Abbreviations

AIC

Akaike Information Criterion

ANC

Antenatal Care

aOR

adjusted Odds Ratio

BIC

Bayesian information criterion

CI

Confidence Interval

CSA

Central Statistical Agency

DHS

Demographic and Health Survey

ICC

Intra Class Correlation Coefficient

ICF

Inner-City Fund

IDA

Iron deficiency Anemia

IFAS

Iron Folic Acid Supplementation

Hgb

Hemoglobin

KDHS

Kenyan Demographic and Health Survey

LL

Log-Likelihood

MOR

Median Odds Ratio

NGOs

Non-Governmental Organizations

NTDs

Neural Tube Defects

PCV

Proportional Change in Variance

SDG

Sustainable Development Goal

SSA

sub-Saharan Africa

VIF

Variance Inflation Factor

WHO

World Health Organization

Data Availability

All relevant data are within the manuscript.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Tefera AA, Ibrahim NA, Umer AA. Adherence to iron and folate supplementation and associated factors among women attending antenatal care in public health facilities at Covid-19 pandemic in Ethiopia. PLOS Glob Public Health. 2023;3(1):e0000825. doi: 10.1371/journal.pgph.0000825 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bahati F. Determinants of adherence to iron-folic acid supplementation during pregnancy among mothers seeking maternal and child healthcare 0-6 months post-delivery at Kakamega County Referral Hospital: JKUAT-COHES. 2022.
  • 3.World Health Organization. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. 2008.
  • 4.World Health Organization. Developing and validating an iron and folic acid supplementation indicator for tracking progress towards global nutrition monitoring framework targets. 2018. Available from: https://iris.who.int/bitstream/handle/10665/274372/9789241514637-eng.pdf?sequence=1&isAllowed=y
  • 5.Metz J. A high prevalence of biochemical evidence of vitamin B12 or folate deficiency does not translate into a comparable prevalence of anemia. Food Nutr Bull. 2008;29(2 Suppl):S74-85. doi: 10.1177/15648265080292S111 [DOI] [PubMed] [Google Scholar]
  • 6.Viswanathan M, Urrutia RP, Hudson KN, Middleton JC, Kahwati LC. Folic Acid Supplementation to Prevent Neural Tube Defects: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2023;330(5):460–6. doi: 10.1001/jama.2023.9864 [DOI] [PubMed] [Google Scholar]
  • 7.Knudsen VK, Hansen HS, Ovesen L, Mikkelsen TB, Olsen SF. Iron supplement use among Danish pregnant women. Public Health Nutr. 2007;10(10):1104–10. [DOI] [PubMed] [Google Scholar]
  • 8.Wulff M, Ekström E-C. Iron supplementation during pregnancy in Sweden: to what extent is the national recommendation followed? Acta Obstet Gynecol Scand. 2003;82(7):628–35. doi: 10.1034/j.1600-0412.2003.00186.x [DOI] [PubMed] [Google Scholar]
  • 9.Gathigi LN. Factors influencing utilization of iron and folic acid supplementation services among women attending antenatal clinic at Nyeri Provincial Hospital Kenya. Jomo Kenyatta University of Agriculture & Technology; 2011. [Google Scholar]
  • 10.Cesar JA, Dumith S de C, Chrestani MAD, Mendoza-Sassi RA. Iron supplementation among pregnant women: results from a population-based survey study. Rev Bras Epidemiol. 2013;16(3):729–36. doi: 10.1590/s1415-790x2013000300016 [DOI] [PubMed] [Google Scholar]
  • 11.Mithra P, Unnikrishnan B, Rekha T, Nithin K, Mohan K, Kulkarni V, et al. Compliance with iron-folic acid (IFA) therapy among pregnant women in an urban area of south India. Afr Health Sci. 2014;14(1):255–60. doi: 10.4314/ahs.v14i1.39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ba DM, Ssentongo P, Kjerulff KH, Na M, Liu G, Gao X, et al. Adherence to Iron Supplementation in 22 Sub-Saharan African Countries and Associated Factors among Pregnant Women: A Large Population-Based Study. Curr Dev Nutr. 2019;3(12):nzz120. doi: 10.1093/cdn/nzz120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fite MB, Roba KT, Oljira L, Tura AK, Yadeta TA. Compliance with Iron and Folic Acid Supplementation (IFAS) and associated factors among pregnant women in Sub-Saharan Africa: A systematic review and meta-analysis. PLoS One. 2021;16(4):e0249789. doi: 10.1371/journal.pone.0249789 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Desta M, Kassie B, Chanie H, Mulugeta H, Yirga T, Temesgen H, et al. Adherence of iron and folic acid supplementation and determinants among pregnant women in Ethiopia: a systematic review and meta-analysis. Reprod Health. 2019;16(1):182. doi: 10.1186/s12978-019-0848-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sendeku FW, Azeze GG, Fenta SL. Adherence to iron-folic acid supplementation among pregnant women in Ethiopia: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2020;20(1):138. doi: 10.1186/s12884-020-2835-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Temesgen H, Woyraw W, Feleke FW, Mezgebu GS, Taye K, Awoke T. Iron folic acid supplementation adherence level and its associated factors among pregnant women in Ethiopia: a multilevel complex data analysis of 2019 Ethiopian mini demographic and health survey data. Front Nutr. 2024;11:1348275. doi: 10.3389/fnut.2024.1348275 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Haile D, Tabar L, Lakew Y. Differences in spatial distributions of iron supplementation use among pregnant women and associated factors in Ethiopia: evidence from the 2011 national population based survey. BMC Pregnancy Childbirth. 2017;17(1):33. doi: 10.1186/s12884-016-1210-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gebremedhin S, Samuel A, Mamo G, Moges T, Assefa T. Coverage, compliance and factors associated with utilization of iron supplementation during pregnancy in eight rural districts of Ethiopia: a cross-sectional study. BMC Public Health. 2014;14:607. doi: 10.1186/1471-2458-14-607 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ogundipe O, Hoyo C, Østbye T, Oneko O, Manongi R, Lie RT, et al. Factors associated with prenatal folic acid and iron supplementation among 21,889 pregnant women in Northern Tanzania: a cross-sectional hospital-based study. 2012;12:1–10. [DOI] [PMC free article] [PubMed]
  • 20.World Health Organization. Daily iron and folic acid supplementation during pregnancy. 2024. Available from: https://www.who.int/tools/elena/interventions/daily-iron-pregnancy [PubMed]
  • 21.McGuire S. World Health Organization. Comprehensive Implementation Plan on Maternal, Infant, and Young Child Nutrition. Geneva, Switzerland, 2014. Adv Nutr. 2015;6(1):134–5. doi: 10.3945/an.114.007781 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Gardner W, Kassebaum N. Global, regional, and national prevalence of anemia and its causes in 204 countries and territories, 1990–2019. Curr Develop Nutrit. 2020;4:nzaa053_35. [Google Scholar]
  • 23.World Health Organization. Anaemia WHO Fact sheet 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/ANAEMIA
  • 24.Ministry of Health RoK. National Iron and Folic Acid Supplementation Communication Strategy, Nairobi, Kenya: Government of Kenya. 2013. Available from: https://www.advancingnutrition.org/sites/default/files/202103/tagged_ifas_national_comunication_strategy_2013-2017.pdf
  • 25.Liyew AM, Tesema GA, Alamneh TS, Worku MG, Teshale AB, Alem AZ, et al. Prevalence and determinants of anemia among pregnant women in East Africa; A multi-level analysis of recent Demographic and Health Surveys. PLoS One. 2021;16(4):e0250560. doi: 10.1371/journal.pone.0250560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Obeagu EI, Abdi AA, Uche FO, Ngwoke AO, Danchal CV, Obeagu GU, et al. Anaemia among pregnant women: a review in Africa. 2023.
  • 27.Agegnehu CD, Tesema GA, Teshale AB, Alem AZ, Yeshaw Y, Kebede SA, et al. Spatial distribution and determinants of iron supplementation among pregnant women in Ethiopia: a spatial and multilevel analysis. Arch Public Health. 2021;79(1):143. doi: 10.1186/s13690-021-00669-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mulugeta SS. Geographical disparities and determinants of adherence to iron folate supplementation among pregnant women in Ethiopia: spatial and multilevel analysis of the Ethiopian Mini Demographic and Health Survey of 2019. BMJ Open. 2022;12(9):e061900. doi: 10.1136/bmjopen-2022-061900 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Getachew M, Abay M, Zelalem H, Gebremedhin T, Grum T, Bayray A. Magnitude and factors associated with adherence to Iron-folic acid supplementation among pregnant women in Eritrean refugee camps, northern Ethiopia. BMC Pregnancy Childbirth. 2018;18(1):83. doi: 10.1186/s12884-018-1716-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Seidu H, Gaa PK, Mogre V. Adherence to Iron and Folic Acid Supplementation Among Pregnant Women From Northern Ghana. Nutr Metab Insights. 2024;17:11786388231218664. doi: 10.1177/11786388231218664 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience: summary: highlights and key messages from the World Health Organization’s 2016 global recommendations for routine antenatal care. World Health Organization; 2018. [Google Scholar]
  • 32.World Atlas. Kenya maps and facts, 2025. Available from: https://www.worldatlas.com/maps/kenya [Google Scholar]
  • 33.Worldometer. Elaboration of data by United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects. 2025.
  • 34.KNBS, ICF. Kenya Demographic and Health Survey 2022 Key Indicators Report, Nairobi, Kenya, and Rockville, Maryland, USA: KNBS and ICF. 2023. Available from: https://dhsprogram.com/pubs/pdf/PR143/PR143.pdf
  • 35.World Bank. How does infrastructure contribute to health service delivery in Kenya? Available from: https://blogs.worldbank.org/en/transport/how-does-infrastructure-contribute-health-service-deliverykenya#:~:text=To%20improve%20our%20understanding%20of%20this%20issue%2C%20a,between%20infrastructure%20and%20the%20provision%20of%20health%20services2023
  • 36.Mwaura HM, Kamanu TK, Kulohoma BWJ. Sub-national disparities in indicators of maternal mortality in Kenya: insights from demographic health surveys towards attaining SDG 3. J Women Health Develop. 2024;7(3):29–40. [Google Scholar]
  • 37.Mishra V, Vaessen M, Boerma JT, Arnold F, Way A, Barrere B, et al. HIV testing in national population-based surveys: experience from the Demographic and Health Surveys. Bull World Health Organ. 2006;84(7):537–45. doi: 10.2471/blt.05.029520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.World Health Organization. Daily iron and folic acid supplementation during pregnancy. 2024. Available from: https://www.who.int/tools/elena/interventions/daily-iron-pregnancy [PubMed]
  • 39.Terefe B, Jembere MM, Abie Mekonnen B. Minimum meal frequency practice and associated factors among children aged 6–23 months old in The Gambia: a multilevel mixed effect analysis. Scientific Reports. 2023;13(1):22607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Nkoka O, Chuang T-W, Chen Y-H. Multilevel Analysis of Factors Associated with Treatment-Seeking Behaviors among Caregivers with Febrile Children in Malawi. Am J Trop Med Hyg. 2019;100(6):1454–65. doi: 10.4269/ajtmh.18-0900 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Tesfie TK, Endalew B, Birhanu MY, Haimanot AB, Mneneh AL, Mengie MG, et al. Spatial distribution of inadequate meal frequency and its associated factors among children aged 6-23 months in Ethiopia: Multilevel and spatial analysis. PLoS One. 2024;19(7):e0306646. doi: 10.1371/journal.pone.0306646 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Yadeta TA, Mengistu B, Gobena T, Regassa LD. Spatial pattern of perinatal mortality and its determinants in Ethiopia: Data from Ethiopian Demographic and Health Survey 2016. PLoS One. 2020;15(11):e0242499. doi: 10.1371/journal.pone.0242499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Gebreamlak B, Dadi AF, Atnafu A. High Adherence to Iron/Folic Acid Supplementation during Pregnancy Time among Antenatal and Postnatal Care Attendant Mothers in Governmental Health Centers in Akaki Kality Sub City, Addis Ababa, Ethiopia: Hierarchical Negative Binomial Poisson Regression. PLoS One. 2017;12(1):e0169415. doi: 10.1371/journal.pone.0169415 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Kamau MW, Mirie W, Kimani S. Compliance with iron and folic acid supplementation (IFAS) and associated factors among pregnant women: results from a cross-sectional study in Kiambu County, Kenya. BMC Public Health. 2018;18:1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Assefa H, Abebe SM, Sisay M. Magnitude and factors associated with adherence to Iron and folic acid supplementation among pregnant women in Aykel town, Northwest Ethiopia. BMC Pregnancy Childbirth. 2019;19(1):296. doi: 10.1186/s12884-019-2422-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Lyoba WB, Mwakatoga JD, Festo C, Mrema J, Elisaria E. Adherence to Iron-Folic Acid Supplementation and Associated Factors among Pregnant Women in Kasulu Communities in North-Western Tanzania. Int J Reprod Med. 2020;2020:3127245. doi: 10.1155/2020/3127245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wemakor A, Garti H, Akai MM, Napari AA, Dankyi-Frimpomaa J. Prevalence and factors associated with compliance to iron and folic acid supplementation in pregnancy in Tamale Metropolis, Ghana. Nutrire. 2020;45:1–10. [Google Scholar]
  • 48.Goshu YA, Liyeh TM, Ayele AS, Zeleke LB, Kassie YT. Women’s Awareness and Associated Factors on Preconception Folic Acid Supplementation in Adet, Northwestern Ethiopia, 2016: Implication of Reproductive Health. J Nutr Metab. 2018;2018:4936080. doi: 10.1155/2018/4936080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Kondale M, Tumebo T, Gultie T, Megersa T, Yirga H. Timing of first antenatal care visit and associated factors among pregnant women attending anatal clinics in Halaba Kulito governmental health institutions, 2015. J Women Health Care. 2016;5(308):2167-0420. [Google Scholar]
  • 50.Manyeh AK, Amu A, Williams J, Gyapong M. Factors associated with the timing of antenatal clinic attendance among first-time mothers in rural southern Ghana. BMC Pregnancy Childbirth. 2020;20(1):47. doi: 10.1186/s12884-020-2738-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Begum K, Ouédraogo CT, Wessells KR, Young RR, Faye MT, Wuehler SE, et al. Prevalence of and factors associated with antenatal care seeking and adherence to recommended iron-folic acid supplementation among pregnant women in Zinder, Niger. Matern Child Nutr. 2018;14 Suppl 1(Suppl 1):e12466. doi: 10.1111/mcn.12466 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Manasa K, Chandrakumar S, Prashantha B. Assessment of compliance with iron-folic acid therapy during pregnancy among postnatal mothers in a tertiary care centre, Mysuru. Int J Community Med Public Health. 2019;6:1665–-9. [Google Scholar]
  • 53.USAID. Cross-country Comparison of Anemia Prevalence, Reach, and Use of Antenatal Care and Anemia Reduction Interventions. 2011. Available from: https://www.advancingnutrition.org/sites/default/files/202103/Progress_Reducing_Anemia_Women_2011.pdf
  • 54.Taye B, Abeje G, Mekonen A. Factors associated with compliance of prenatal iron folate supplementation among women in Mecha district, Western Amhara: a cross-sectional study. Pan Afr Med J. 2015;20:43. doi: 10.11604/pamj.2015.20.43.4894 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Abdullahi H, Gasim GI, Saeed A, Imam AM, Adam I. Antenatal iron and folic acid supplementation use by pregnant women in Khartoum, Sudan. BMC Res Notes. 2014;7:498. doi: 10.1186/1756-0500-7-498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Mithra P, Unnikrishnan B, Rekha T, Nithin K, Mohan K, Kulkarni V, et al. Compliance with iron-folic acid (IFA) therapy among pregnant women in an urban area of south India. Afr Health Sci. 2014;14(1):255–60. doi: 10.4314/ahs.v14i1.39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Cesar JA, Dumith S de C, Chrestani MAD, Mendoza-Sassi RA. Iron supplementation among pregnant women: results from a population-based survey study. Rev Bras Epidemiol. 2013;16(3):729–36. doi: 10.1590/s1415-790x2013000300016 [DOI] [PubMed] [Google Scholar]
  • 58.Ummair M, Durrani A, Jamshaid M, Amjad M, Gul M, Khan JZ, et al. Compliance with iron and folic acid supplements among pregnant women attending tertiary care hospital in the district of Peshawar. Cureus. 2025;17(2). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Merga RT, Birhane M, Dhinsa M, Muleta B, Jemal J, Belay MM. Determinants of compliance with iron-folic acid supplementation among pregnant mothers in Bule Hora district, Southern Ethiopia: unmatched case-control study. BMC Public Health. 2025;25(1):832. doi: 10.1186/s12889-025-22005-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Lavanya P, Jayalakshmy R, Rajaa S, Mahalakshmy T. Adherence to iron and folic acid supplementation among antenatal mothers attending a tertiary care center, Puducherry: A mixed-methods study. J Family Med Prim Care. 2020;9(10):5205–11. doi: 10.4103/jfmpc.jfmpc_721_20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Gebremariam ADG, Tiruneh SA, Abate BA, Engidaw MT, Asnakew DTA. Adherence to iron with folic acid supplementation and its associated factors among pregnant women attending antenatal care follow up at Debre Tabor General Hospital, Ethiopia, 2017. 2019. [DOI] [PMC free article] [PubMed]
  • 62.Molla T, Guadu T, Muhammad EA, Hunegnaw MT. Factors associated with adherence to iron folate supplementation among pregnant women in West Dembia district, northwest Ethiopia: a cross sectional study. BMC Res Notes. 2019;12(1):6. doi: 10.1186/s13104-019-4045-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Tarekegn M, Wubshet M, Atenafu A, Derso T, Woretaw A. Antenatal care and mothers’ education improved iron-folic acid adherence at Denbiya district health centers, Northwest Ethiopia: using pills count method. Arch Public Health. 2019;77:1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Birhanu TM, Birarra MK, Mekonnen FA. Compliance to iron and folic acid supplementation in pregnancy, Northwest Ethiopia. BMC Res Notes. 2018;11(1):345. doi: 10.1186/s13104-018-3433-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Gebremariam AD, Tiruneh SA, Abate BA, Engidaw MT, Asnakew DT. Adherence to iron with folic acid supplementation and its associated factors among pregnant women attending antenatal care follow up at Debre Tabor General Hospital, Ethiopia, 2017. PLoS One. 2019;14(1):e0210086. doi: 10.1371/journal.pone.0210086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Alene AG, Olayemi OO, Berhane Y. Timing and factors associated with early antenatal visits among pregnant women in west Gojjam, northwest Ethiopia. African J Midwifery Women Health. 2021;15(2):1–11. doi: 10.12968/ajmw.2020.0023 [DOI] [Google Scholar]
  • 67.Niang K, Faye A, Diégane Tine JA, Diongue FB, Ndiaye B, Ndiaye MB, et al. Determinants of Iron Consumption among Pregnant Women in Southern Senegal. Open J Obstet Gynecol. 2017;07(01):41–50. doi: 10.4236/ojog.2017.71005 [DOI] [Google Scholar]
  • 68.Roy MP, Mohan U, Singh SK, Singh VK, Srivastava AK. Socio-economic determinants of adherence to iron and folic acid tablets among rural ante-natal mothers in Lucknow, India. National J Commun Med. 2013;4(03):386–91. [Google Scholar]
  • 69.Nisar YB, Dibley MJ, Mir AM. Factors associated with non-use of antenatal iron and folic acid supplements among Pakistani women: a cross sectional household survey. BMC Pregnancy Childbirth. 2014;14:305. doi: 10.1186/1471-2393-14-305 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Kanchan Thapa

PONE-D-24-57968Adherence to iron-folic acid supplementation and its associated factors among pregnant women in Kenya: a multilevel data analysis of 2022 Kenyan national population based surveyPLOS ONE

Dear Dr. Alemu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please rework on all your section taking reference with the published paper in PLOS one. Please respond to all the concern of the peer reviewer. Special attention should be given for formatting of Table and Figures along with English. 

Please submit your revised manuscript by Apr 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Kanchan Thapa, MPH, MPhil

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

3. We note that your Data Availability Statement is currently as follows: “All relevant data are within the manuscript and in Supporting Information files.”

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

4. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 2 in your text; if accepted, production will need this reference to link the reader to the Table.

Additional Editor Comments:

Dear Authors,

Remove reference in Abstract.

Pleas reorganize the paper based on reviewer comments. Please work on Abstract, Background, Methods, Results, Discussion and Conclusion section. Follow standard for reporting aOR.

Figure and Table should be formatted based on PLOS One guideline and scientific standards.

Provide a letter of granting permission for data usage for analysis as supplementary file.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This study provides relevant and high scientific value information on maternal health, focusing on sociodemographic factors that could be associated with adherence to iron and folic acid supplementation among pregnant women in Kenya. Its relevance in the context of public health is indisputable, given the direct impact these micronutrients have on maternal-fetal health.

Abstract:

The authors are advised to remove the abbreviation “KDHS 2022” from the keywords section, as its inclusion does not significantly contribute to the indexing or visibility of the article and may be redundant.

Introduction:

The article adequately emphasizes the importance of investigating the factors influencing adherence to iron and folic acid supplementation, highlighting it as a critical public health issue with substantial implications for maternal-fetal well-being. However, it is suggested that the authors structure a clear research question at the end of the introduction, aligned with the study's stated objective. This will enhance the clarity and direction of the study.

Method:

The methodological design is appropriate and aligned with the study's objective, supporting the validity of the results. Furthermore, the authors have provided an adequate operational definition of the independent variables, contributing to the reproducibility and understanding of the approach employed.

Implications for Policy, Practice, and Future Research:

The authors are encouraged to restructure the section dedicated to the study's implications, developing and justifying each aspect in separate paragraphs. Specifically:

1. Implications for Public Health Policy: It is recommended to draft a specific paragraph addressing how the findings can inform the design or implementation of policies that promote greater adherence to iron and folic acid supplementation in contexts similar to Kenya.

2. Implications for Healthcare Practice: A second paragraph could focus on practical recommendations for healthcare providers, highlighting strategies to improve education, access, and adherence among pregnant women.

3. Implications for Future Research: A third paragraph should detail priority areas that require further exploration. This section must emphasize the knowledge gaps identified in the study and their relevance for optimizing adherence to iron and folic acid supplementation, with an emphasis on the sociocultural and economic context of Kenya.

Together, these adjustments will strengthen the study’s contribution, enhancing its clarity and utility for both the scientific community and decision-makers in the field of public health.

Reviewer #2: Overall comment

This study is well-conducted, and the researchers are commended for their work thorough evaluating magnitude of Adherence to iron-folic acid supplementation and its associated factors among pregnant women in Kenya. The study is effectively structured, with a clear identification of the impact of Adherence to iron-folic acid supplementation with well thought recommendations for public health interventions. However, to enhance its credibility and ensure clear communication of the findings, the researchers should address the minor comments and suggestions provided above. Once these revisions are made, the study will be ready for publication and will provide valuable insights into malaria prevention and control.

Reviewer #3: Major Concerns:

1. Repetition of contents in introduction:

• The discussion on iron deficiency and its impact on pregnancy is repeated in different paragraphs (e.g., lines 68–74, 95–103). These can be merged into one concise section.

• The importance of iron-folic acid supplementation is reiterated in multiple places (lines 75–83 and 110–119). A single well-structured paragraph would be more effective.

• The risk factors influencing adherence to IFAS (lines 104–109) could be more succinctly stated. Avoid listing too many studies separately and instead synthesize the findings.

• The discussion on policy recommendations and improving adherence is scattered throughout the introduction. Instead, create a distinct section towards the end that summarizes key points effectively.

2. Justification of Study Significance:

• The introduction provides a solid background on the importance of iron-folic acid supplementation but does not sufficiently highlight the novelty of the study in comparison to existing literature. The authors should clarify how their findings contribute to addressing gaps in current knowledge.

3. Methodological Clarity:

• The study mentions the use of a multivariable multilevel mixed-effects logistic regression model but does not provide sufficient justification for selecting this specific approach. Could the authors elaborate on why this method was chosen over alternative statistical models?

• The selection criteria for variables in the final multivariable model should be explicitly detailed. Why was a p-value threshold of 0.25 used in the bi-variable model for inclusion in the multivariable analysis?

• The manuscript states that 8460 weighted study participants were used. However, were there any missing data, and if so, how was this handled?

• The manuscript refers to a pooled analysis, but it only utilizes data from the 2022 survey. The authors should clarify whether they intended to conduct a pooled analysis over multiple years or rephrase this to reflect that only 2022 data were analyzed.

4. Interpretation of Results:

• The discussion on adherence prevalence could be expanded by comparing it with similar studies in other regions, particularly in sub-Saharan Africa.

• The study finds that women with higher education levels are more likely to adhere to iron-folic acid supplementation. What implications does this have for public health interventions aimed at less-educated women?

• The study mentions a 70% reduction in adherence among women who start antenatal care in the third trimester. The authors should discuss the practical implications of this finding, including policy recommendations to encourage earlier antenatal visits.

5. Policy and Practical Recommendations:

• While the study concludes that adherence is associated with maternal age, education, and antenatal visits, there is limited discussion on policy-level interventions. What are the specific strategies that the Kenyan health system can implement to improve adherence rates?

• The study suggests that healthcare professionals should be trained, but it would be helpful to specify the kind of training and how it could be practically implemented.

6. Sentence inconsistency:

• Correct the sentence in line 104

• Rephrase the section "Implications for policy, practice and future research". Need to improve the sentence-making standard. Especially look at lines 478-480

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Perdomo Sandoval, Luis Albeiro

Reviewer #2: Yes:  First name: Habtamu Molla

Last name: Ayele

Affilation: Maternal and Child Health Directorate, Federal Ministry of Health, Addis Ababa, Ethiopia.

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review comments_Adherence to iron-folic acid supplementation.pdf

pone.0329458.s002.pdf (112.2KB, pdf)
Attachment

Submitted filename: PLOS One -Iron Adherence_ Review.docx

pone.0329458.s003.docx (13.2KB, docx)
PLoS One. 2025 Aug 1;20(8):e0329458. doi: 10.1371/journal.pone.0329458.r002

Author response to Decision Letter 1


26 Mar 2025

March 26, 2025

Dear Editors and Reviewers

We have submitted these authors' responses to peer-review comments and questions for a manuscript entitled: Adherence to iron-folic acid supplementation and its associated factors among pregnant women in Kenya: a multilevel data analysis of 2022 Kenyan national population-based survey.

Dear Editor, first, we would like to thank the PLOS ONE Editorial Office members, especially the chief editor, who timely assigned the competent academic editor and facilitated the progress of the review forum. Second, our special thanks go to the academic editor for his editorial contribution and for assigning the potential skilled and experienced reviewers in the field promptly. Moreover, our deepest gratitude goes to the esteemed reviewers for their constructive comments and scientific contributions that helped us to improve the quality of this manuscript. Dear academic Editor and reviewers, we have made the necessary corrections and responses to those comments raised by academic editor and reviewers point by point, page by page, and line by line sequentially. Accordingly, we have added the authors’ responses in the review forum, as well as the revised manuscript and the tracked changes to the manuscript on the web page.

With regards!

Gebrie Getu Alemu

gebryegetu27@gmail.com

University of Gondar, Ethiopia

PO. Box 196

Corresponding Author

Attachment

Submitted filename: Response to Reviewers.docx

pone.0329458.s005.docx (54KB, docx)

Decision Letter 1

Kanchan Thapa

PONE-D-24-57968R1Adherence to iron-folic acid supplementation and its associated factors among pregnant women in Kenya: a multilevel data analysis of 2022 Kenyan national population-based surveyPLOS ONE

Dear Dr. Alemu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I have some concern in the manuscript. I enjoyed reading your manuscript which still requires revision. I have included my comments below. I suggest to rework in almost in all the section. Remove unnecessary wording, try to make it catchy with important information. Provide an opportunity to proofread to your colleagues before submission which may help to reduce unnecessary words. 

Please submit your revised manuscript by Jun 04 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Kanchan Thapa, MPH, MPhil

Academic Editor

PLOS ONE

Additional Editor Comments:

Dear Authors

I suggest to make your abstract catchy, don’t mention all the categories of the age. Try to mention one or main highlight about the categories of age.

We dont need a separate research question. Therefore, please incorporate in the last paragraph of the introduction section.

Why not to separate into three different section for this?- Study setting, design and periods.

Source population- it is better to mention the number of the source population. How many women delivered in the year 2022 and provide the relevant citation. Line 218- cite the relevant reference.

Ethical approval and consent to participate- Please reorganize the section. Mention about the details how the ethical consideration was done, how informed consent was taken, how the interview was done? Please read the KDHS once again for details.

Line 216-265. Please include all the information in a table a supplementary file. Just brief about the variables you have considered for analysis in a paragraph.

Incorporate the (Data management and analysis) into statistical analysis section.

Results-

Table 1. Please take care of elements mention?

Maternal age should mention in years, right? Maternal age( Years)

Also, how to mention 45-49 (73) and 0.86? – I think it is better to incorporate into previous category.

It is important to create a subsection for- Prevalence of adherence to iron-folic acid supplementation among 350 pregnant women in Kenya. I found the result was mention in only a line. I think it is better not to mention a separate section.

Present your findings in a analytical way.

Discussion-

Line 397-404- Please highlight your findings, what is your major findings of your study. Please review relevant literature to organize your section.

You need to compare and contrast your result. Please compare and contrast your result and provide the reason why it is so? – In your example- Line 404-406, how it is similar to WHO recommendation, what does WHO talks about IFAS? Also, why it is similar to Ethiopia?

The discussion section is loosely written. Please rewrite the whole section, reviewing similar literature published in PLOS One. I found the reference are not organized as per the standard, please follow the standard guideline of PLOS One. See the full reference in the link- https://pubmed.ncbi.nlm.nih.gov/31777771/

What is SSA in the reference 12 in the text in the discussion section, I need to read the reference list to understand it. Please mention the full form whenever necessary?

Take care of all the referencing throughout the paper.

Strengths and limitations of the study-

Separate into two paragraph. What are the strengths, policy relevance, global relevance, developing countries relevancy, why it is important, what is the extra that this report explored rather than DHS report?

What are the limitations?

Conclusion- Write your conclusion based on your results, some of the information about WHO recommendation need to go to the discussion section.

I found this section is very important- Implications for policy, practice and future research. However, I suggest to limit your words and incorporate into the strengths and limitation section.

Figure 2. Is it important to mention outcome status in the figure? Please take care of your color used? Make the figure standard, display the number and percentage together. Legend should mention in standard way, why to include black background here?

I found reference are not accurately organized in reference list. Please take care while citing and referring. See reference 16- MoH Kenya. National Iron & Folic Acid Supplementation, where can we read the document?

To cite KDHS, you need to use the given reference in the report. Please read the report once again. I found the given citation for KDHS is- KNBS and ICF. 2023. Kenya Demographic and Health Survey 2022. Key Indicators Report. Nairobi, Kenya, and Rockville, Maryland, USA: KNBS and ICF.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Aug 1;20(8):e0329458. doi: 10.1371/journal.pone.0329458.r004

Author response to Decision Letter 2


5 May 2025

May 05, 2025

Rebuttal letter

To: PLOS ONE Editorial Office

Authors’ point-by-point Responses to a Manuscript ID: PONE-D-24-57968R1

Dear Editor in Chief, Greetings.

We have submitted these authors' responses to peer-review comments and questions for a manuscript entitled: Adherence to iron-folic acid supplementation and its associated factors among pregnant women in Kenya: a multilevel data analysis of the 2022 Kenyan Demographic and health Survey

Dear Editor, first, we would like to thank the PLOS ONE Editorial Office members, especially the chief editor, who timely assigned the competent academic editor and facilitated the progress of the review forum. Second, our special thanks go to the academic editor for his editorial contribution and for assigning the potential skilled and experienced reviewers in the field promptly. Moreover, our deepest gratitude goes to the esteemed reviewers for their constructive comments and scientific contributions that helped us to improve the quality of this manuscript. Dear academic Editor, we have made the necessary corrections and responses to those additional comments raised by the editors point by point, page by page, and line by line sequentially. Accordingly, we have added the authors’ responses in the review forum, as well as the revised manuscript and the tracked changes to the manuscript on the web page.

With kind regards!

Gebrie Getu Alemu

gebryegetu27@gmail.com

University of Gondar, Ethiopia

PO. Box 196

Corresponding Author

Attachment

Submitted filename: Response_to_Reviewers_auresp_2.docx

pone.0329458.s006.docx (50KB, docx)

Decision Letter 2

Kanchan Thapa

Adherence to iron-folic acid supplementation and its associated factors among pregnant women in Kenya: a multilevel data analysis of the 2022 Kenyan Demographic and Health Survey

PONE-D-24-57968R2

Dear Dr. Alemu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kanchan Thapa, MPH, MPhil

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear Authors

Greetings

I am happy to read the revised version of the paper and I appreciate your works which will definitely help to guide the policy making, program implementation and academia in Kenya and in the world.

Congratulations

Best

Kanchan

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #4: All comments have been addressed

Reviewer #5: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #4: Yes

Reviewer #5: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #4: Yes

Reviewer #5: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #4: Yes

Reviewer #5: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #4: Yes

Reviewer #5: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #4: The manuscript is technically sound and reads well. The statistical analysis is sound, and discussion is well written.

Reviewer #5: The authors have addressed all the comments made by the reviewers. The manuscript is technically sound and the conclusions are supported by data. Statsistical analysis have been performed rigorously. Data has been made available. The manuscript has been presented in an intelligible manner using standard English

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #4: No

Reviewer #5: Yes:  Lucas Banda

**********

Acceptance letter

Kanchan Thapa

PONE-D-24-57968R2

PLOS ONE

Dear Dr. Alemu,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Mr. Kanchan Thapa

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Lists of individual and community level factors affecting adherence to iron-folic acid supplementation among pregnant women in Kenya, KDHS 2022.

    (DOCX)

    pone.0329458.s001.docx (13KB, docx)
    Attachment

    Submitted filename: Review comments_Adherence to iron-folic acid supplementation.pdf

    pone.0329458.s002.pdf (112.2KB, pdf)
    Attachment

    Submitted filename: PLOS One -Iron Adherence_ Review.docx

    pone.0329458.s003.docx (13.2KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0329458.s005.docx (54KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewers_auresp_2.docx

    pone.0329458.s006.docx (50KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES